SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud V...
November 11 2015 - 3:02PM
Business Wire
Levi & Korsinsky LLP announces that it has commenced an
investigation of HeartWare International Inc. (“HeartWare” or the
“Company”) (NasdaqGS:HTWR) concerning possible violations of
federal securities laws by certain officers and directors.
On October 13, 2015, HeartWare announced that the company may
not reinitiate enrollment in its MVAD heart pump clinical trials in
November 2015, as previously announced. On the announcement of this
news, the share price of HeartWare stock has plunged as much as
$7.63 per share, or more than 17%, during intraday trading from its
October 12, 2015 closing price of $44.03 to trade under $37.00 per
share on October 13, 2015. To obtain additional information about
the investigation, go to:
http://zlk.9nl.com/heartware-international-htwr
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151111006361/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Apr 2023 to Apr 2024